Based on our findings, we expect that present and future models and compounds will provide genetic and pharmacological tools to assess the contribution of LPLA2 and BMP to pathogenic mechanisms of viral infection and neurodegeneration, and pave the way for potential therapeutic avenues for these disorders. Here, PLA2G15 is linked to viral infectious disease.